about
Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib).Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemiaTargeted drug discovery for pediatric leukemia.Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors.Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.Plasma cell leukemia: from biology to treatment.Natural compounds for pediatric cancer treatment.Highly sensitive detection of E2 activity in ubiquitination using an artificial RING finger.Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines.PAN3-PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia.Bortezomib for the treatment of acute lymphoblastic leukemia
P2860
Q33742779-25EADD01-E86A-4145-8B40-EB66279FF4E5Q35687836-9D9BECA3-12DE-4FD9-970A-B26DB0384E38Q36955757-D11D14D7-2836-4E97-947B-ECB8F87A350CQ36989223-AE4C212B-3591-47BD-9CC5-B2303F4698D1Q37377911-A6872001-76A2-48A6-9C1A-24E0BE124DF2Q37688848-3620F204-46F5-4FDD-93BE-12B340DE571CQ38380625-39BD851E-1837-417D-ACFD-E66B663504F0Q38663897-B27E232E-D39D-47B2-AFCB-D97E0FFB3ADEQ38721008-E2A8AC36-FF98-4601-9994-7D14DDCBE06FQ38809124-909672C3-C19A-44B2-A8DA-128D00723F26Q38949575-E67B2A6C-A6A2-419C-B0BA-4F8E4A9E739EQ39034873-D8E34F76-5AF8-4FC5-B92B-B63E4C28308CQ52348448-8C2B755F-8C55-413D-9D84-F540D890DDA8Q57286691-CE67CCE7-46DB-415D-BF0A-EA16EA90ADA8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Proteasome inhibitors in acute leukemia.
@en
type
label
Proteasome inhibitors in acute leukemia.
@en
prefLabel
Proteasome inhibitors in acute leukemia.
@en
P2093
P2860
P356
P1476
Proteasome inhibitors in acute leukemia
@en
P2093
Denise Niewerth
Gerrit Jansen
Gertjan Kaspers
Jacqueline Cloos
P2860
P304
P356
10.1586/ERA.13.4
P50
P577
2013-03-01T00:00:00Z